Goodwill and Intangible Assets

9 Months Ended

Sep. 30, 2025

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill and Intangible Assets, Net

Goodwill

Goodwill represents the excess of the aggregate purchase price over the fair value of net identifiable assets acquired in a business combination. The Company evaluates goodwill for impairment on an annual basis on October 1, and more frequently whenever events or substantive changes in circumstances indicate that it is more likely than not that the carrying value of a reporting unit exceeds its fair value. Assumptions used in an impairment test require significant judgment, therefore, they are subject to change based on facts and circumstances present at each date goodwill is evaluated for impairment. The Company determined there were no events or circumstances during the three and nine months ended September 30, 2025 that would more likely than not reduce the fair value of the reporting unit below its carrying value. If, in future periods, the financial performance of the reporting unit does not meet expectations, or a prolonged decline occurs in the market place of our common stock, it may cause a material change in the results of the impairment assessment and result in future impairment to goodwill.

The changes in the carrying amount of goodwill as of September 30, 2025 and December 31, 2024 are as follows:


	Goodwill, net

	(In thousands)
Balance as of December 31, 2024 (1)	$	222,554

Foreign exchange adjustment	3,962
Balance as of September 30, 2025 (1)	$	226,516

(1) As of September 30, 2025 and December 31, 2024, the accumulated impairment balance was $72.4 million.

During the nine months ended September 30, 2024, the Company recorded a non-cash impairment charge of $3.6 million in the condensed consolidated statements of operations, to recognize a full impairment of goodwill associated with its WildHealth reporting unit, which was sold in 2024. There were no other impairments of goodwill during the three and nine months ended September 30, 2024.

Intangible Assets, Net

Intangible assets, net are summarized as follows:


	September 30,		December 31,
	2025		2024

	(In thousands)
Patents:
Gross carrying amount	$	18,571	$	17,609
Accumulated amortization	(3,055)		(2,539)
Net carrying amount	$	15,516	$	15,070
Weighted average amortization period	13.5 years		12.7 years

Amortization expense is recognized over the estimated useful life of the asset. Aggregate amortization expense for intangible assets and finance leases, net was $0.2 million and $0.6 million for the three and nine months ended September 30, 2025, respectively, and $3.7 million and $11.6 million for the three and nine months ended September 30, 2024, respectively.

There were no impairments of intangible assets during the three and nine months ended September 30, 2025. The Company recognized a non-cash impairment charge of $2.2 million included in Impairment of intangibles and other assets in the condensed consolidated statements of operations during the nine months ended September 30, 2024, related to intangible assets associated with its WildHealth reporting unit, which was sold in 2024.

As of September 30, 2025, estimated annual amortization expense for the next five years and thereafter is as follows:


	Estimated Amortization Expense
	(In thousands)
Remainder of 2025	$	168
2026	610
2027	578
2028	577
2029	561
Thereafter	13,022
Total	$	15,516